---
pmid: '19619542'
title: Mdmx enhances p53 ubiquitination by altering the substrate preference of the
  Mdm2 ubiquitin ligase.
authors:
- Okamoto K
- Taya Y
- Nakagama H
journal: FEBS Lett
year: '2009'
full_text_available: false
doi: 10.1016/j.febslet.2009.07.021
---

# Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
**Authors:** Okamoto K, Taya Y, Nakagama H
**Journal:** FEBS Lett (2009)
**DOI:** [10.1016/j.febslet.2009.07.021](https://doi.org/10.1016/j.febslet.2009.07.021)

## Abstract

1. FEBS Lett. 2009 Sep 3;583(17):2710-4. doi: 10.1016/j.febslet.2009.07.021. Epub
 2009 Jul 18.

Mdmx enhances p53 ubiquitination by altering the substrate preference of the 
Mdm2 ubiquitin ligase.

Okamoto K(1), Taya Y, Nakagama H.

Author information:
(1)National Cancer Center Research Institute, Early Oncogenesis Research 
Project, Tokyo, Japan.

mdm2 and mdmx oncogenes play essential yet non-redundant roles in synergistic 
inactivation of the tumor suppressor, p53. While Mdm2 inhibits p53 activity 
mainly by augmenting its ubiquitination, the functional role of Mdmx on p53 
ubiquitination remains obscure. In transfected H1299 cells, Mdmx augmented 
Mdm2-mediated ubiquitination of p53. In in vitro ubiquitination assays, the 
Mdmx/Mdm2 heteromeric complex, in comparison to the Mdm2 homomer, showed 
enhanced ubiquitinase activity toward p53 and the reduced auto-ubiquitination of 
Mdm2. Alteration of the substrate specificity via binding to Mdmx may contribute 
to efficient ubiquitination and inactivation of p53 by Mdm2.

DOI: 10.1016/j.febslet.2009.07.021
PMID: 19619542 [Indexed for MEDLINE]
